MNK Therapy in Releasing the Superficial Fascia for Patients With AAS: an Assessor-blinded, Randomised Controlled Trial

Launched by SEN-WEI LU · Feb 16, 2024

Keywords

ClinConnect Summary

This clinical trial is studying the effectiveness and safety of a new treatment called MNK therapy for patients suffering from an acute ankle sprain (AAS). Acute ankle sprains happen when the ligaments in the ankle are stretched or torn, often due to a sudden twist or fall. In this trial, participants will be divided into two groups. One group will receive MNK therapy, which aims to relieve tension in the superficial fascia (a layer of tissue under the skin), while the other group will get traditional acupuncture treatment. The goal is to see which method helps patients feel better more quickly.

To participate in this study, individuals need to be between 16 and 55 years old and have experienced an ankle injury within the last week. They should also have symptoms like swelling, pain, and bruising in the affected ankle, but must not have any fractures. Participants will be asked to sign a consent form to show they agree to take part in the study. It's important to note that people with certain medical conditions, those who are pregnant or breastfeeding, or anyone with severe needle anxiety won't be eligible to join. This trial is currently recruiting participants, and it aims to provide valuable information for both patients and healthcare providers on the best treatment options for ankle sprains.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • 16 to 55 years old
• • Clear history of trauma within 1 to 7 days
• • Presence of localized swelling, pain, bruising, and limping symptoms in the ankle joint
• • Pain in the ankle joint upon resistance
• • No accompanying fractures
• • Diagnosis of acute ankle injury according to the "Diagnostic and Therapeutic Criteria of Traditional Chinese Medicine"
• • No prior treatment before participating in this therapy
• • Willingness to participate in this study and signing of the informed consent form
• Exclusion Criteria:
• • Individuals with clear indications for surgery
• • Those suffering from gout, rheumatoid arthritis, joint tuberculosis, joint tumors, etc.
• • Pregnant or breastfeeding women
• • Individuals with serious primary diseases of the cardiovascular, liver, kidney, brain, and hematopoietic systems
• • Those with local skin lesions or skin diseases
• • Individuals with coagulation dysfunction
• • Those with severe fear of needles
• • Individuals unwilling to comply with the treatment regimen